Max Robotics — Global Service Robot Directory + US Certification

About

E. Haglind is a leading colorectal and urologic surgeon whose research has shaped evidence-based practice in surgical oncology, particularly regarding prostate and colorectal cancer management. Her work is distinguished by a commitment to resolving clinical controversies through rigorous prospective trials. She is the principal investigator behind the landmark LAPPRO trial, a large, prospectively controlled study that has produced highly cited findings on surgical outcomes. One of her key contributions demonstrated that robot-assisted laparoscopic prostatectomy significantly reduces the risk of postoperative inguinal and incisional hernias compared to open surgery (21 citations). Another influential study from the same trial revealed that patients who engage in physical activity before radical prostatectomy take less sick leave after surgery, highlighting the value of preoperative conditioning (19 citations). Beyond urology, Haglind has addressed critical debates in colorectal surgery, advocating for high-level evidence to validate new techniques like complete mesocolic excision (34 citations). Her work bridges the gap between surgical innovation and patient-centered outcomes, directly influencing postoperative recovery protocols and surgical decision-making. With her focus on resolving uncertainty through controlled data, Haglind remains a pivotal figure in advancing the quality and safety of modern surgical care.